Brickell research partner sues company for alleged bad faith practices
Stock price fell over 25 percent in Thursday trading
BOULDER and MIAMI — A Florida pharmaceutical company is suing Boulder-based Brickell Biotech Inc. (Nasdaq: BBI) over a series of alleged bad-faith practices, a suit that Brickell said could hamper milestone payments from a separate funding partner.
The suit, filed in the U.S. District Court of Southern Florida, claims Brickell and Miami-based Bodor Laboratories Inc. signed an agreement in December 2012 to license Bodor’s patents and treatments for excessive sweating. That agreement had several development milestones that Brickell was supposed to reach over seven years, but allegedly failed to do so.
Bodor also claims that a…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
BOULDER — Even with the COVID-10 pandemic several years in the rearview mirror, it remains…
-
Columbine Health Systems will host Dementia Week, a series of free events devoted to educating…
-
Boulder Community Health this month became the first facility in Colorado to offer patients a…
-
Nextera Healthcare LLC and ImagineMD have combined to form a single direct-primary-care organization for employer…
